2017
DOI: 10.4070/kcj.2017.0011
|View full text |Cite
|
Sign up to set email alerts
|

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 34 publications
0
1
0
Order By: Relevance
“…Intravenous immunoglobulin (IVIG) has been the standard treatment of choice for Kawasaki disease (KD) with aspirin 1). As KD is considered by obvious immune activation related to cytotoxic anti-endothelial cell antibodies and increased cytokine production, IVIG helps to interact with these diverse parts of immune and vascular systems to relieve inflammation 2)3)4)…”
mentioning
confidence: 99%
“…Intravenous immunoglobulin (IVIG) has been the standard treatment of choice for Kawasaki disease (KD) with aspirin 1). As KD is considered by obvious immune activation related to cytotoxic anti-endothelial cell antibodies and increased cytokine production, IVIG helps to interact with these diverse parts of immune and vascular systems to relieve inflammation 2)3)4)…”
mentioning
confidence: 99%